NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Operating Expenses (2010 - 2026)

NextPlat's (NXPL) quarterly Operating Expenses came in at $4.8 million in Q2 2026, up 2.31% year-over-year from $4.7 million in Q2 2025, and up 6.78% quarter-over-quarter from $4.5 million in Q1 2026.

Analysis

NextPlat (NXPL) Operating Expenses (2010 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Operating Expenses for 16 consecutive years, with $4.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Operating Expenses rose 2.31% year-over-year to $4.8 million in Q2 2026; TTM through Jun 2026 was -$1.8 million, a 174.28% decrease from a year earlier, with the FY2025 full-year figure at $19.9 million, down 50.28% from the prior year.
  • Operating Expenses was $4.8 million for Q2 2026 at NextPlat, up from $4.5 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $27.9 million in Q2 2024 and troughed at -$30.6 million in Q4 2024.
  • A 5-year average of $4.4 million and a median of $4.8 million in 2025 frame the typical range for Operating Expenses.
  • Across the five-year window, Operating Expenses surged 559.95% in 2023 and sank 671.73% in 2024, its largest moves.
  • Over 5 years, Operating Expenses stood at $3.1 million in 2022, then surged by 71.72% to $5.3 million in 2023, then slumped by 671.73% to -$30.6 million in 2024, then grew by 11.91% to -$26.9 million in 2025, then soared by 117.91% to $4.8 million in 2026.
  • The last three Operating Expenses figures came in at $4.8 million (Q2 2026), $4.5 million (Q1 2026), and -$26.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 1.29 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 1.45 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 356.56 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 195.34 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 2.11 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 225.58 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -65.41 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 53.74 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 16.14 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 4.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.82 Mn
Mar 31, 2026 4.52 Mn
Dec 31, 2025 -26.91 Mn
Sep 30, 2025 15.74 Mn
Jun 30, 2025 4.71 Mn
Mar 31, 2025 4.95 Mn
Dec 31, 2024 -30.55 Mn
Sep 30, 2024 23.37 Mn
Jun 30, 2024 27.89 Mn
Mar 31, 2024 6.71 Mn
Dec 31, 2023 5.34 Mn
Sep 30, 2023 18.77 Mn
Jun 30, 2023 6.31 Mn
Mar 31, 2023 4.11 Mn
Dec 31, 2022 3.11 Mn
Sep 30, 2022 2.84 Mn
Jun 30, 2022 2.10 Mn
Mar 31, 2022 1.64 Mn
Dec 31, 2021 3.92 Mn
Sep 30, 2021 2.73 Mn